Paragon Private Wealth Management LLC lifted its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 23.9% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,114 shares of the medical equipment provider’s stock after acquiring an additional 215 shares during the period. Paragon Private Wealth Management LLC’s holdings in Intuitive Surgical were worth $581,000 at the end of the most recent reporting period.
A number of other large investors have also recently made changes to their positions in the stock. Meriwether Wealth & Planning LLC bought a new position in shares of Intuitive Surgical in the fourth quarter worth $537,000. Gallagher Capital Advisors LLC bought a new position in shares of Intuitive Surgical in the fourth quarter worth $2,690,000. Moran Wealth Management LLC boosted its holdings in shares of Intuitive Surgical by 1.7% in the fourth quarter. Moran Wealth Management LLC now owns 1,778 shares of the medical equipment provider’s stock worth $928,000 after acquiring an additional 29 shares during the period. Main Street Research LLC boosted its stake in Intuitive Surgical by 1.9% during the fourth quarter. Main Street Research LLC now owns 79,531 shares of the medical equipment provider’s stock valued at $41,512,000 after buying an additional 1,482 shares during the period. Finally, Zurcher Kantonalbank Zurich Cantonalbank boosted its stake in Intuitive Surgical by 24.5% during the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 187,398 shares of the medical equipment provider’s stock valued at $97,814,000 after buying an additional 36,865 shares during the period. 83.64% of the stock is owned by institutional investors.
Analyst Ratings Changes
ISRG has been the subject of several research analyst reports. Royal Bank of Canada lifted their price objective on Intuitive Surgical from $611.00 to $641.00 in a research note on Monday, January 27th. Evercore ISI lifted their price objective on Intuitive Surgical from $490.00 to $530.00 in a research note on Monday, January 27th. Piper Sandler reaffirmed an “overweight” rating and set a $670.00 price target (up previously from $538.00) on shares of Intuitive Surgical in a research note on Friday, January 24th. Morgan Stanley raised Intuitive Surgical from an “equal weight” rating to an “overweight” rating and lifted their price target for the stock from $522.00 to $650.00 in a research note on Monday, December 2nd. Finally, Citigroup lifted their price target on Intuitive Surgical from $640.00 to $711.00 and gave the stock a “buy” rating in a research note on Friday, January 24th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and sixteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $613.10.
Insider Activity at Intuitive Surgical
In other Intuitive Surgical news, CFO Jamie Samath sold 270 shares of Intuitive Surgical stock in a transaction that occurred on Tuesday, December 10th. The stock was sold at an average price of $540.15, for a total transaction of $145,840.50. Following the sale, the chief financial officer now directly owns 8,757 shares of the company’s stock, valued at approximately $4,730,093.55. The trade was a 2.99 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, SVP Mark Brosius sold 489 shares of the business’s stock in a transaction that occurred on Friday, March 7th. The stock was sold at an average price of $533.18, for a total value of $260,725.02. Following the completion of the sale, the senior vice president now directly owns 2,091 shares in the company, valued at approximately $1,114,879.38. This represents a 18.95 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 13,579 shares of company stock worth $7,756,844 in the last 90 days. Company insiders own 0.90% of the company’s stock.
Intuitive Surgical Price Performance
Shares of NASDAQ:ISRG opened at $518.26 on Monday. Intuitive Surgical, Inc. has a 1 year low of $364.17 and a 1 year high of $616.00. The company has a market cap of $184.59 billion, a PE ratio of 80.85, a P/E/G ratio of 5.85 and a beta of 1.43. The stock’s 50-day moving average is $571.36 and its 200 day moving average is $531.85.
Intuitive Surgical Company Profile
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Read More
- Five stocks we like better than Intuitive Surgical
- 3 Warren Buffett Stocks to Buy Now
- Institutional Investors Bet $1B on These 4 Stocks—Should You?
- ESG Stocks, What Investors Should Know
- One Must-Buy Stock and One to Avoid as Tariffs Shake the Market
- Low PE Growth Stocks: Unlocking Investment Opportunities
- These 4 Tech ETFs Just Hit 50-Day Lows—Time to Buy?
Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report).
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.